Efficacy of donepezil in mild cognitive impairment
暂无分享,去创建一个
S. Salloway | A. Kluger | S. Ferris | R. Goldman | Dinesh Kumar | S. Richardson | A Kluger | S Salloway | S Ferris | R. S. Goldman | R Goldman | T Griesing | D Kumar | S Richardson | T. Griesing | D. Kumar
[1] Steven H. Ferris,et al. Patterns of Motor Impairment in Normal Aging, Mild Cognitive Decline, and Early Alzheimer' Disease , 1997 .
[2] S. Gauthier. Update on Diagnostic Methods, Natural History and Outcome Variables in Alzheimer’s Disease , 1998, Dementia and Geriatric Cognitive Disorders.
[3] R. Petersen,et al. Development of Cognitive Instruments for Use in Clinical Trials of Antidementia Drugs: Additions to the Alzheimer's Disease Assessment Scale That Broaden Its Scope , 1997, Alzheimer disease and associated disorders.
[4] Dirk Deleu,et al. A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD. , 2001, Neurology.
[5] R D Hill,et al. Very mild senile dementia of the Alzheimer type. II. Psychometric test performance. , 1989, Archives of neurology.
[6] Gastone G. Celesia,et al. A 30-Week Randomized Controlled Trial of High-Dose Tacrine in Patients With Alzheimer's Disease , 1994 .
[7] Rachelle S. Doody,et al. DONEPEZIL STUDY GROUP. A 24-WEEK, DOUBLE BLIND, PLACEBO-CONTROLLED TRIAL OF DONEPEZIL IN PATIENTS WITH ALZHEIMER'S DIS-EASE , 1998 .
[8] M. Hamilton. A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.
[9] H. Gertz,et al. The prognosis of mild cognitive impairment in the elderly. , 1998, Journal of neural transmission. Supplementum.
[10] B. Winblad,et al. A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD , 2001, Neurology.
[11] S. Wisniewski,et al. Cholinesterase inhibitor treatment alters the natural history of Alzheimer's disease , 2002, Journal of neurology, neurosurgery, and psychiatry.
[12] E G Tangalos,et al. Mild cognitive impairment. When is it a precursor to Alzheimer's disease? , 2000, Geriatrics.
[13] Physostigmine: improvement of long-term memory processes in normal humans. , 1979, Science.
[14] S H Ferris,et al. Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. The Alzheimer's Disease Cooperative Study. , 1997, Alzheimer disease and associated disorders.
[15] R. Mohs,et al. A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease , 1998, Neurology.
[16] E. Tangalos,et al. Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .
[17] H.-J. Möller,et al. The Effects of Donepezil in Alzheimer’s Disease – Results from a Multinational Trial1 , 1999, Dementia and Geriatric Cognitive Disorders.
[18] C. P. Hughes,et al. Psychometric differentiation of mild senile dementia of the Alzheimer type. , 1984, Archives of neurology.
[19] J. Yesavage,et al. Donepezil and flight simulator performance: Effects on retention of complex skills , 2002, Neurology.
[20] D. Geldmacher,et al. Donepezil Is Associated with Delayed Nursing Home Placement in Patients with Alzheimer's Disease , 2003, Journal of the American Geriatrics Society.
[21] L. Schneider,et al. Clinical Evaluation of Global Change in Alzheimer's Disease: Identifying Consensus , 1996, Journal of geriatric psychiatry and neurology.
[22] S. Folstein,et al. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.
[23] R. Katzman.,et al. Pathological verification of ischemic score in differentiation of dementias , 1980, Annals of neurology.
[24] J. Morris,et al. Very mild senile dementia of the Alzheimer type. I. Clinical assessment. , 1989, Archives of neurology.
[25] B. Winblad,et al. Mild cognitive impairment--an early stage of Alzheimer's disease? , 1998, Journal of neural transmission. Supplementum.
[26] Gwenn S. Smith,et al. The radiologic prediction of Alzheimer disease: the atrophic hippocampal formation. , 1993, AJNR. American journal of neuroradiology.
[27] J. Morris,et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assesment of Alzheimer's disease , 1989, Neurology.
[28] J. Price,et al. Mild cognitive impairment represents early-stage Alzheimer disease. , 2001, Archives of neurology.
[29] J. Morris,et al. Current concepts in mild cognitive impairment. , 2001, Archives of neurology.
[30] J. Morris. The Clinical Dementia Rating (CDR) , 1993, Neurology.
[31] P. Tariot,et al. A 5-month, randomized, placebo-controlled trial of galantamine in AD , 2000, Neurology.
[32] B. Reisberg,et al. Mild cognitive impairment in the elderly , 1991, Neurology.
[33] R. Mohs,et al. A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients , 2001, Neurology.
[34] P. Maruff,et al. The neuropsychology of preclinical Alzheimer's disease and mild cognitive impairment , 2000, Neuroscience & Biobehavioral Reviews.
[35] S H Ferris,et al. Neuropsychological Prediction of Decline to Dementia in Nondemented Elderly , 1999, Journal of geriatric psychiatry and neurology.
[36] G. Chazot,et al. The Physiology and Pharmacology of Melatonin in Humans , 1998, Hormone Research in Paediatrics.